Advertisement

Top Stories

Cell & Gene
Cell and Gene Roundup: CAR T Breaks New Ground

A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression
Biopharma
Jonathan Van-Tam on COVID’s Next Phase

Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
Cell & Gene
FDA Fast-Tracks Off-the-Shelf CAR-T for Aggressive T-Cell Cancers

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.
Cell & Gene
CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial

Browse By Topic

Cell & Gene Small Molecules Biopharma Future of Pharma
Advertisement

Recommended

Advertisement

Voices in the Community

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

power-list
Our celebration of the most inspirational and influential leaders in medicine.
Find out more
Product Image
Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile
Product Image
Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

Product Image

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

Latest News

All the latest Medicine Maker articles.

Biopharma

GLP-1 Analysis: Riding the Wave of Peptide Innovation

April 9, 2026

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

12 min read

Advertisement